Document Detail


Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.
MedLine Citation:
PMID:  15181487     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This randomized, double-blind, parallel-group study compared the efficacy and safety of famciclovir administered at 250 mg thrice daily with acyclovir 800 mg 5 times daily for the treatment of acute uncomplicated herpes zoster in immunocompetent adults. A total of 55 patients participated in this trial. Twenty seven patients (49.1%) were randomized into the famciclovir plus placebo treatment group and 28 (50.9%) into the acyclovir plus placebo group. Six of the 55 patients did not complete the study. Two of these patients were in the famciclovir plus placebo group and dropped out due to deviation from the study protocol. Four patients in the acyclovir plus placebo group did not complete the study protocol due to adverse events (n = 2), deviation from the protocol (n = 1), or loss to follow-up (n = 1). Treatment was initiated within 72 h of onset of the zoster rash and was continued for 7 days. When treatment was initiated within 72 h, famciclovir was as effective as acyclovir for healing the cutaneous lesion, as indicated by the time to full crusting, loss of acute phase pain, loss of vesicles, and loss of crusts. Famciclovir was well tolerated and had a more favorable adverse event profile compared to acyclovir. Constipation, hematuria, and glycosuria were the most commonly reported adverse events, but only constipation was considered to have a possible relationship to the treatment. In conclusion, famciclovir, administered less frequently and at lower unit doses than acyclovir, is an effective treatment for uncomplicated herpes zoster.
Authors:
Meng-Chuan Shen; Hsi-Hsun Lin; Susan Shin-Jung Lee; Yao-Shen Chen; Ping-Chen Chiang; Yung-Ching Liu
Related Documents :
7009087 - Clinical efficacy of ribavirin in the treatment of genital herpes simplex virus infection.
20701667 - Different therapeutic strategies for burning mouth syndrome: preliminary data.
819597 - Clinical trials of topical interferon therapy of ulcerative viral keratitis.
6384817 - Systemic alpha-interferon therapy of multiple sclerosis.
18197917 - The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis.
17432077 - Nasal fracture reduction: local versus general anaesthesia.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi     Volume:  37     ISSN:  1684-1182     ISO Abbreviation:  J Microbiol Immunol Infect     Publication Date:  2004 Apr 
Date Detail:
Created Date:  2004-06-07     Completed Date:  2004-12-03     Revised Date:  2007-06-21    
Medline Journal Info:
Nlm Unique ID:  100956211     Medline TA:  J Microbiol Immunol Infect     Country:  China (Republic: 1949- )    
Other Details:
Languages:  eng     Pagination:  75-81     Citation Subset:  IM    
Affiliation:
Section of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, 386 Ta-chung 1st Road, Kaohsiung, Taiwan 813, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2-Aminopurine / administration & dosage,  adverse effects*,  analogs & derivatives*,  therapeutic use*
Acyclovir / administration & dosage,  adverse effects*,  therapeutic use*
Adult
Aged
Antiviral Agents / administration & dosage,  adverse effects,  therapeutic use*
Constipation / chemically induced
Double-Blind Method
Female
Glycosuria / chemically induced
Hematuria / chemically induced
Herpes Zoster / drug therapy*
Humans
Male
Middle Aged
Placebos
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/Placebos; 104227-87-4/famciclovir; 452-06-2/2-Aminopurine; 59277-89-3/Acyclovir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Symptom development and timing of menarche: a longitudinal study.
Next Document:  Prognostic implications of myoclonic jerk in children with enterovirus infection.